Hep A vaccination not cost effective for patients with chronic hep C

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 265, 2000-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Is the NHS willing to help clinicians and patients reduce uncertainties about the effects of treatments?

By Chalmers Robert JG   Jobling Ray   Chalmers Iain  

Clinical Medicine, Vol. 5, Iss. 3, 2005-05 ,pp. : 230-234

Royal College Of Physicians

Access to resources Recommend Favorite

Hepatitis C Treatment in Patients with Drug Addiction: Clinical Management of Interferon-Alpha-Associated Psychiatric Side Effects

By  

Current Drug Abuse Reviews, Vol. 1, Iss. 2, 2008-06 ,pp. : 177-187

Bentham Science Publishers

Access to resources Recommend Favorite

Biochemical and Hematological Side Effects of Clofazimine in Leprosy Patients

By Costa Queiroz R.H.   de SOUZA A.M.   Sampaio S.V.   Melchior E.  

Pharmacological Research, Vol. 46, Iss. 2, 2002-08 ,pp. : 191-194

Academic Press

Access to resources Recommend Favorite

Further evidence for the association between 5-HT_2C receptor gene polymorphisms and extrapyramidal side effects in male schizophrenic patients

By Gunes Arzu   Dahl Marja-Liisa   Spina Edoardo   Scordo Maria  

European Journal of Clinical Pharmacology, Vol. 64, Iss. 5, 2008-05 ,pp. : 477-482

Springer Publishing Company

Access to resources Recommend Favorite